scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0954-6111(98)90281-5 |
P698 | PubMed publication ID | 9692095 |
P2093 | author name string | Ayres JG | |
Hill FG | |||
Boldy DA | |||
Cowen P | |||
Short PE | |||
Chambers DC | |||
P2860 | cites work | von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death | Q33611676 |
Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome | Q34258088 | ||
Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique | Q39515168 | ||
Physiological mechanisms in coagulation and fibrinolysis | Q39708066 | ||
Population-based distributions of haemostatic variables | Q39708097 | ||
Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms | Q40394411 | ||
A reliable marker of endothelial cell dysfunction: does it exist? | Q40401880 | ||
Effect of exercise on F VIII-complex: Proportional increase of ristocetin cofactor (von Willebrand factor) and F VIII-AGN, but disproportional increase of F VIII-AHF | Q40644248 | ||
The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein | Q40738906 | ||
C reactive protein concentration as screening test for bacterial infection in febrile children | Q40813215 | ||
C-reactive protein for rapid monitoring of infections of the central nervous system | Q40845126 | ||
Predicted values: how should we use them? | Q41130291 | ||
Subcellular platelet factor VIII antigen and von Willebrand factor | Q42940232 | ||
Measurement error | Q43189733 | ||
Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine | Q44841479 | ||
Markers for impending adult respiratory distress syndrome | Q45215987 | ||
Comparative behaviour of the components of the factor VIII complex in acute myocardial infarction. | Q53868783 | ||
Coagulation and fibrinolysis in acute mountain sickness and beginning pulmonary edema | Q57123096 | ||
Value of the C-reactive protein test in the differentiation of bacterial and viral pneumonia | Q67296548 | ||
Factor-VIII activity and antigen, platelet count and biochemical changes after adrenoceptor stimulation | Q67583323 | ||
Correlation of circulating von Willebrand factor levels with cardiovascular hemodynamics | Q67898893 | ||
Release of von Willebrand factor antigen (vWF:Ag) and eicosanoids during acute injury to the isolated rat lung | Q68139834 | ||
Clinical correlations of plasma angiotensin converting enzyme (ACE) activity in systemic sclerosis: a longitudinal study of plasma ACE level, endothelial injury and lung involvement | Q68485265 | ||
von Willebrand factor is an acute phase reactant in man | Q69058730 | ||
Fibrinolysis in critically ill patients | Q69223339 | ||
Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects | Q70362744 | ||
Microalbuminuria and endothelial dysfunction in essential hypertension | Q72682381 | ||
Altered Factor VIII in Acute Respiratory Failure | Q72765701 | ||
P433 | issue | 3 | |
P921 | main subject | bronchitis | Q173022 |
P304 | page(s) | 395-400 | |
P577 | publication date | 1998-03-01 | |
P1433 | published in | Respiratory Medicine | Q2659932 |
P1476 | title | Plasma levels of von Willebrand factor antigen in acute bronchitis and in a normal population | |
P478 | volume | 92 |
Q39523647 | Chronic respiratory symptoms, von Willebrand factor and longitudinal decline in FEV1. |
Q28192888 | In vitro bleeding test with PFA-100-aspects of controlling individual acetylsalicylic acid induced platelet inhibition in patients with cardiovascular disease |
Q37187005 | Markers of vascular perturbation correlate with airway structural change in asthma |
Q57557608 | Microalbuminuria, von Willebrand factor and fibrinogen levels as markers of the severity in COPD exacerbation |
Search more.